Martingale Asset Management L P Generation Bio Co. Transaction History

Martingale Asset Management L P

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$4.68 - $8.34 $28 - $50	-6 Reduced 0.01%	74,304 $395,000
Q2 2022 Aug 11, 2022	SELL	$4.87 - $9.41 $19,606 - $37,884	-4,026 Reduced 5.14%	74,310 $487,000
Q1 2022 May 12, 2022	BUY	$4.16 - $7.76 $251,193 - $468,572	60,383 Added 336.34%	78,336 $574,000
Q4 2021 Feb 11, 2022	BUY	$5.99 - $24.97 $21,743 - $90,641	3,630 Added 25.34%	17,953 $127,000
Q3 2021 Nov 12, 2021	BUY	$20.0 - $27.43 $286,460 - $392,879	14,323 New	14,323 $359,000

50M

100

200

Ticker GBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,011,200
Market Cap $146M
Description
Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Martingale Asset Management L P with notifications on news.